Medtronic said it has implanted its new supersmall leadless pacemaker in its first U.S. patient as part of a global clinical trial of the device. This comes a few weeks after rival St. Jude Medical hit the same milestone with its own competing product.
St. Jude Medical stock spiked 6% in the last week in the wake of progress with its leadless pacemaker, an analyst upgrade and the perception that its rebound story is continuing.
It's a story that could confirm the worst fears of med tech implant wearers at the highest level of U.S. government: Some time during the first half of 2013, hackers reportedly broke into the computer networks of the big three medical device makers, and the breach might have stayed open for "several months."
In 2011, Boston Scientific was listed among 759 other organizations as a victim of attacks by China-based hackers. The report made the cyber cold war public knowledge but companies are still struggling to protect themselves, with the San Francisco Chronicle now reporting Boston Scientific and fellow medtech giants Medtronic and St. Jude Medical have been hacked.
A leadless pacemaker, approved for use in Europe, has found its way into its first U.S. patient, St. Jude Medical announced Thursday. Dr. Vivek Reddy implanted the Nanostim leadless pacemaker at The Mount Sinai Hospital in New York, starting a pivotal trial for FDA approval.
Boston Scientific CEO Mike Mahoney would like to make hay while the sun shines--and for the medical device giant that means widening the gap between it and its big-three rivals, before billion-dollar rainclouds crack open in the untapped U.S. market for renal denervation.
On Jan. 2, 2014, a pacemaker was implanted under my right clavicle, with two wire leads snaked through two veins and into my heart. My experience as a patient showed me how limited the true choices are for most U.S. cardiac patients, despite the marketing hype around innovation in the industry.
St. Jude Medical announced a shakeup and reorganization this morning, combining its cardiovascular and implantables divisions into one R&D organization that spans the company.
A U.S. district court is allowing 5 product liability lawsuits filed against St. Jude Medical to move forward, despite the company's effort to dismiss claims that it failed to warn patients about potential problems with its now-recalled Riata ICD leads.
After buying Nanostim just a few months ago, St. Jude Medical has implanted the company's eponymous leadless pacemaker in a patient in the U.K., a global first for a wireless device of its kind postapproval.